RPS15A was reported to be potentially involved in hepatocellular carcinoma, progression of breast cancer, lung adenocarcinoma, prostate cancer, glioblastoma, colorectal cancer, and acute myeloid leukemia as an oncogene [84–87]. Here, RPS15A is linked to prostate cancer.